Over the past 12 months, 0 insiders at Aerovate Therapeutics, Inc. filed 0 open-market SEC Form 4 transactions on AVTE: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 24 | Rajeev M. ShahDirector,TenPercentOwner | BUY | 928.1K | $1.67 | $1.5M |
| Jun 14, 24 | George A EldridgeSEE REMARKS | SELL | 15.0K | $25.03 | $375K |
| Jun 14, 24 | Marinus VerwijsCHIEF TECHNICAL OFFICER | SELL | 10.6K | $25.00 | $265K |
| Jun 13, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 6.0K | $24.50 | $147K |
| May 17, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 3.9K | $21.86 | $82K |
| May 16, 24 | Timothy P NoyesCHIEF EXECUTIVE OFFICER | SELL | 8.7K | $21.92 | $187K |
| May 2, 24 | Marinus VerwijsCHIEF TECHNICAL OFFICER | SELL | 2.0K | $21.02 | $42K |
| May 1, 24 | Timothy P NoyesCHIEF EXECUTIVE OFFICER | SELL | 9.0K | $20.87 | $184K |
| Apr 17, 24 | Benjamin T DakeSEE REMARKS | SELL | 6.4K | $23.97 | $144K |
| Apr 17, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 3.7K | $23.33 | $82K |
| Apr 16, 24 | Timothy P NoyesCHIEF EXECUTIVE OFFICER | SELL | 5.5K | $24.94 | $137K |
| Apr 10, 24 | George A EldridgeSEE REMARKS | SELL | 6.7K | $27.56 | $180K |
| Apr 9, 24 | David S. GrayzelDirector | SELL | 11.9K | $28.15 | $334K |
| Apr 1, 24 | Benjamin T DakeSEE REMARKS | SELL | 3.3K | $31.97 | $106K |
| Apr 1, 24 | George A EldridgeSEE REMARKS | SELL | 12.5K | $31.23 | $390K |
| Apr 1, 24 | Timothy P NoyesCHIEF EXECUTIVE OFFICER | SELL | 4.5K | $31.95 | $130K |
| Apr 1, 24 | Marinus VerwijsCHIEF TECHNICAL OFFICER | SELL | 3.8K | $30.00 | $110K |
| Mar 28, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 9.0K | $29.50 | $266K |
| Mar 27, 24 | Benjamin T DakeSEE REMARKS | SELL | 11.1K | $27.97 | $310K |
| Mar 25, 24 | Benjamin T DakeSEE REMARKS | SELL | 3.4K | $28.01 | $96K |
| Mar 19, 24 | Marinus VerwijsCHIEF TECHNICAL OFFICER | SELL | 2.8K | $26.46 | $73K |
| Mar 18, 24 | Benjamin T DakeSEE REMARKS | SELL | 27.5K | $26.48 | $707K |
| Mar 18, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 6.4K | $26.40 | $165K |
| Mar 13, 24 | George A EldridgeSEE REMARKS | SELL | 2.0K | $25.02 | $50K |
| Mar 12, 24 | George A EldridgeSEE REMARKS | SELL | 2.1K | $25.05 | $51K |
| Mar 11, 24 | George A EldridgeSEE REMARKS | SELL | 3.4K | $26.31 | $86K |
| Mar 8, 24 | George A EldridgeSEE REMARKS | SELL | 114 | $25.00 | $3K |
| Mar 7, 24 | George A EldridgeSEE REMARKS | SELL | 22.4K | $25.00 | $560K |
| Mar 7, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 9.0K | $24.50 | $220K |
| Feb 23, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 511 | $19.50 | $10K |
| Feb 20, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 2.6K | $20.58 | $52K |
| Feb 5, 24 | Ralph NivenCHIEF SCIENTIFIC OFFICER | SELL | 4.6K | $17.45 | $80K |
| Jan 17, 24 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 4.0K | $19.50 | $78K |
| Jan 5, 24 | Ralph NivenCHIEF SCIENTIFIC OFFICER | SELL | 2.5K | $19.57 | $48K |
| Dec 27, 23 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 125 | $24.50 | $3K |
| Dec 20, 23 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 4.0K | $19.50 | $78K |
| Dec 14, 23 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 9.9K | $19.50 | $193K |
| Dec 13, 23 | Hunter GilliesCHIEF MEDICAL OFFICER | SELL | 2.1K | $19.50 | $41K |
| Dec 6, 23 | Benjamin T DakeSEE REMARKS | SELL | 10.3K | $16.11 | $166K |
| Dec 5, 23 | Ralph NivenCHIEF SCIENTIFIC OFFICER | SELL | 4.6K | $16.30 | $75K |
| Nov 27, 23 | Benjamin T DakeSEE REMARKS | SELL | 12.5K | $16.24 | $203K |
| Nov 24, 23 | Benjamin T DakeSEE REMARKS | SELL | 4.9K | $16.07 | $77K |
| Nov 22, 23 | Benjamin T DakeSEE REMARKS | SELL | 9.4K | $15.17 | $142K |
| Nov 22, 23 | Ralph NivenCHIEF SCIENTIFIC OFFICER | SELL | 13.8K | $15.00 | $207K |
| Nov 1, 23 | Timothy P NoyesCHIEF EXECUTIVE OFFICER | SELL | 1.1K | $10.42 | $11K |
| Nov 1, 23 | Marinus VerwijsCHIEF TECHNOLOGY OFFICER | SELL | 970 | $10.46 | $10K |
| Sep 7, 23 | Benjamin T DakeSEE REMARKS | SELL | 30 | $15.01 | $450 |
| Sep 6, 23 | Benjamin T DakeSEE REMARKS | SELL | 3.9K | $15.06 | $59K |
| Aug 7, 23 | Benjamin T DakeSEE REMARKS | SELL | 9.7K | $16.25 | $151K |
| Jul 28, 23 | Timothy P NoyesCHIEF EXECUTIVE OFFICER | SELL | 5.5K | $18.00 | $99K |
Over the past 12 months, insiders at Aerovate Therapeutics, Inc. filed 0 open-market purchases worth $0 and 0 sales worth $0 on AVTE, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market AVTE insider purchase in our data was $1.5M by Rajeev M. Shah, Director,TenPercentOwner, filed on Jun 17, 24.
0 different insiders at Aerovate Therapeutics, Inc. filed open-market SEC Form 4 transactions on AVTE over the last 12 months.
InsiderTape plots every AVTE insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Aerovate Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →